| P50 | author | Cindy Farquhar | Q19957756 |
| | Kirsten Duckitt | Q94995279 |
| | Anne Lethaby | Q28037237 |
| P2860 | cites work | Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? | Q49207026 |
| | Measurement of menstrual blood loss in patients complaining of menorrhagia | Q67708908 |
| | Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia | Q68139504 |
| | Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid | Q68179811 |
| | Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen | Q68907486 |
| | The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia | Q69456673 |
| | Dysfunctional uterine bleeding | Q69565154 |
| | Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia | Q70179795 |
| | An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia | Q70262309 |
| | A preliminary study of factors influencing perception of menstrual blood loss volume | Q70372183 |
| | Endometrial prostaglandins and menorrhagia: influence of a prostaglandin synthetase inhibitor in vivo | Q70373195 |
| | Hysterectomy and psychiatric disorder: I. Levels of psychiatric morbidity before and after hysterectomy | Q70395044 |
| | Sources of variation in menstrual blood loss | Q70580736 |
| | Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding | Q70753904 |
| | Naproxen in menorrhagia | Q72458289 |
| | Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality | Q72808966 |
| | Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid | Q24655181 |
| | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | Benefits and risks of pharmacological agents used for the treatment of menorrhagia | Q28238233 |
| | Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data | Q30935344 |
| | The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review | Q32048500 |
| | FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. | Q34166420 |
| | A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding | Q34632172 |
| | Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment | Q34911517 |
| | Modern management of menorrhagia | Q35746859 |
| | Comparisons against baseline within randomised groups are often used and can be highly misleading | Q35777357 |
| | Menorrhagia, mechanisms and targeted therapies | Q36173837 |
| | Management of excessive menstrual bleeding in women with hemostatic disorders | Q36308363 |
| | A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding | Q37118911 |
| | The role of prostaglandins and allied substances in uterine haemostasis | Q38594868 |
| | Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study | Q38948116 |
| | A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding | Q41850104 |
| | Studies in the involvement of prostaglandins in uterine symptomatology and pathology | Q42116443 |
| | Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. | Q43325717 |
| | Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia | Q43714228 |
| | A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia | Q44683154 |
| | Treatment of menorrhagia with meclofenamate sodium. | Q45996541 |
| | Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment cha | Q46619982 |
| | Meclofenamate inhibits prostaglandin E binding and adenylyl cyclase activation in human myometrium | Q46878167 |
| P921 | main subject | menstruation | Q12171 |
| | menorrhagia | Q1494682 |
| | inflammation | Q101991 |
| P577 | publication date | 2013-01-31 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding | |